LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Dopamine Agonists and Risk of Lung Cancer in Patients with Restless Legs Syndrome.

Photo by nci from unsplash

To examine the association between long‐term use of dopamine agonists (DAs) and the risk of lung cancer in patients with restless legs syndrome (RLS). Click to show full abstract

To examine the association between long‐term use of dopamine agonists (DAs) and the risk of lung cancer in patients with restless legs syndrome (RLS).

Keywords: lung cancer; patients restless; cancer patients; restless legs; dopamine agonists; risk lung

Journal Title: Pharmacoepidemiology and drug safety
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.